Santarus, VeroScience enter agreement to commercialize CYCLOSET drug for type 2 diabetes
Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.
Read more...
Local youth ready to put best foot forward for diabetes event
Staff writer A Wetaskiwin family is tackling juvenile diabetes head on after their now 11-year-old daughter was diagnosed with the affliction 18 months ago.[...]
Read more...
Decreasing pituitary's sensitivity to insulin could be new target for infertility treatment
Obese women have a well-known risk for infertility, but a new Johns Hopkins Children's Center study has unraveled what investigators there believe is the mechanism that accounts for the risk.
Read more...
Help and support
n upcoming health education events at martin's point health care: at 161 Corporate Drive, Pease International Tradeport, Portsmouth. (800) 260-6681.
Read more...
'Diabetes wave' set to strike
A "tsunami" of diabetes among Asians is about to hit an unprepared Canterbury health system, an ethnic health expert says.
Read more...
|
